ADVERTISEMENT

Coronavirus India Update: Tally Tops 90 Lakh; New Cases Exceed Recoveries

Track all Covid-19 related news and updates relevant for India, here.

A man wearing a protective mask leans against a drinks stall during the festival of Dhanteras at the Lajpat Nagar market in New Delhi. (Photographer: Prashanth Vishwanthan/Bloomberg)
A man wearing a protective mask leans against a drinks stall during the festival of Dhanteras at the Lajpat Nagar market in New Delhi. (Photographer: Prashanth Vishwanthan/Bloomberg)
LIVE FEED
Latest First
  • Oldest First

Confirmed coronavirus cases in India crossed the 90-lakh mark on a day when new cases exceeded recoveries once more.

India added nearly 46,000 fresh cases in a matter of 24 hours, taking the total tally to over 90 lakh in the world’s second-worst infected country, according to the Health Ministry’s update as of 8 a.m. on Nov. 20. That includes nearly over 84 lakh recoveries and 1.3 lakh deaths.

The 45,882 fresh cases were higher than the recoveries reported during the same time period at 44,807, leading to net increase in active cases after 46 days. The country has managed to reduce active cases to below 4.5 lakh since peak of above 10 lakh seen in mid-September.

Active cases now account for less than 5% of the total confirmed Covid-19 cases in India while recoveries dominate the pie with over 93% share. The fatality rate now stands around 1.45%

Key Figures

  • Total number of confirmed coronavirus cases: 90,04,365
  • Active cases: 4,43,794
  • Cured/discharged/migrated: 84,28,409
  • Deaths: 1,32,162
  • Number of fresh cases in 24 hours: 45,882
  • One-day recoveries: 44,807
  • One-day deaths: 584

Global Update

California ordered a one-month curfew and New York added restrictions as states try to curb record Covid-19 cases and limit pressure on hospitals with the Thanksgiving holiday season looming.

Opinion
CDC’s Last-Minute Advice on Travel for Thanksgiving: Don’t Do It

Vaccine Update

Johnson & Johnson expects to know the efficacy of its Covid-19 vaccine candidate come January or February, Chief Scientific Officer Paul Stoffels said at a Reuters health conference. Johnson & Johnson anticipates it will have all 60,000 participants enrolled in the final-stage study by the year’s end. On Wednesday, a J&J spokesperson told Bloomberg it had already enrolled more than 10,000 participants.

Opinion
What a 95% Effective Vaccine Could Do Is Pretty Exciting

Globally, over 56.6 million coronavirus cases have been reported with 1.3 million of them dead.